Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,580 | 15 | 77.9% |
| Travel and Lodging | $5,600 | 27 | 10.5% |
| Consulting Fee | $4,400 | 3 | 8.2% |
| Food and Beverage | $1,794 | 87 | 3.4% |
| Education | $10.75 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MDD US Operations, LLC | $51,386 | 112 | $0 (2024) |
| ABBVIE INC. | $1,451 | 16 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $309.39 | 3 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $127.20 | 2 | $0 (2024) |
| Boston Scientific Corporation | $110.90 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,727 | 73 | MDD US Operations, LLC ($26,168) |
| 2023 | $26,547 | 60 | MDD US Operations, LLC ($25,218) |
| 2022 | $110.90 | 1 | Boston Scientific Corporation ($110.90) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $4.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/18/2024 | ABBVIE INC. | VYALEV (Drug), DUOPA | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/04/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/14/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $5.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $62.53 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 10/07/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 09/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $55.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/29/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $43.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,760.00 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $690.96 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $191.65 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $134.07 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $34.00 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $16.08 | General |
| Category: AMANTADINE | ||||||
| 09/13/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $6.77 | General |
| Category: AMANTADINE | ||||||
| 08/28/2024 | ACADIA Pharmaceuticals Inc | — | Food and Beverage | In-kind items and services | $132.25 | General |
| 08/28/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 556 | 712 | $302,861 | $79,905 |
| 2022 | 3 | 370 | 538 | $186,827 | $65,799 |
| 2021 | 3 | 170 | 205 | $65,965 | $27,482 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 299 | 432 | $183,600 | $50,355 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 171 | 171 | $104,994 | $25,466 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 21 | $6,111 | $1,764 | 28.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 55 | 62 | $4,464 | $1,438 | 32.2% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 13 | 26 | $3,692 | $883.34 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 231 | 393 | $125,441 | $46,988 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 126 | 126 | $60,018 | $18,353 | 30.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 13 | 19 | $1,368 | $458.00 | 33.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 101 | 136 | $42,432 | $18,796 | 44.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 47 | 47 | $21,949 | $8,115 | 37.0% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 22 | 22 | $1,584 | $570.68 | 36.0% |
About Robert Wiggins
Robert Wiggins is a Neurology healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1386006872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Wiggins has received a total of $53,384 in payments from pharmaceutical and medical device companies, with $26,727 received in 2024. These payments were reported across 134 transactions from 5 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,580).
As a Medicare-enrolled provider, Wiggins has provided services to 1,096 Medicare beneficiaries, totaling 1,455 services with total Medicare billing of $173,186. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Charlotte, NC
- Active Since 03/23/2016
- Last Updated 05/22/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1386006872
Products in Payments
- Gocovri (Drug) $25,944
- GOCOVRI (Drug) $25,093
- DUOPA (Drug) $339.44
- Apokyn (Drug) $224.10
- NUPLAZID (Drug) $177.14
- XADAGO (Drug) $123.08
- General - DBS (Device) $110.90
- Qelbree (Drug) $62.53
- VYALEV (Drug) $11.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Charlotte
Jill Conway, Md, MD
Neurology — Payments: $1.5M
Sanjay Iyer, Md, MD
Neurology — Payments: $620,868
Dr. Megan Donnelly, D.o, D.O
Neurology — Payments: $471,292
Danielle Englert Doggett, Md, MD
Neurology — Payments: $224,230
Ardith Courtney, Do, DO
Neurology — Payments: $215,565
Mohammad Bolouri, Md, MD
Neurology — Payments: $184,450